» Articles » PMID: 22962272

DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2012 Sep 11
PMID 22962272
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The exceptional high mortality of lung cancer can be instigated to a high degree by late diagnosis. Despite the plethora of studies on potential molecular biomarkers for lung cancer diagnosis, very few have reached clinical implementation. In this study, we developed a panel of DNA methylation biomarkers and validated their diagnostic efficiency in bronchial washings from a large retrospective cohort. Candidate targets from previous high-throughput approaches were examined by pyrosequencing in an independent set of 48 lung tumor/normal paired. Ten promoters were selected and quantitative methylation-specific PCR (qMSP) assays were developed and used to screen 655 bronchial washings from the Liverpool Lung Project (LLP) subjects divided into training (194 cases and 214 controls) and validation (139 cases and 109 controls) sets. Three statistical models were used to select the optimal panel of markers and to evaluate the performance of the discriminatory algorithms. The final logit regression model incorporated hypermethylation at p16, TERT, WT1, and RASSF1. The performance of this 4-gene methylation signature in the validation set showed 82% sensitivity and 91% specificity. In comparison, cytology alone in this set provided 43% sensitivity at 100% specificity. The diagnostic efficiency of the panel did not show any biases with age, gender, smoking, and the presence of a nonlung neoplasm. However, sensitivity was predictably higher in central (squamous and small cell) than peripheral (adenocarcinomas) tumors, as well as in stage 2 or greater tumors. These findings clearly show the impact of DNA methylation-based assays in the diagnosis of cytologically occult lung neoplasms. A prospective trial is currently imminent in the LLP study to provide data on the enhancement of diagnostic accuracy in a clinical setting, including by additional markers.

Citing Articles

Nutraceutical Potential and Food Safety of Fructose in Soda and Diet Beverages.

Mateo-Fernandez M, Alves-Martinez P, Del Rio-Celestino M, Font R, Merinas-Amo T, Alonso-Moraga A Foods. 2025; 14(4).

PMID: 40002094 PMC: 11854732. DOI: 10.3390/foods14040648.


In Vivo and In Vitro Studies Assessing the Safety of Monosodium Glutamate.

Merinas-Amo T, Merinas-Amo R, Alonso-Moraga A, Font R, Del Rio Celestino M Foods. 2024; 13(23).

PMID: 39683053 PMC: 11640987. DOI: 10.3390/foods13233981.


Epigenetic changes driven by environmental pollutants in lung carcinogenesis: a comprehensive review.

Zhang A, Luo X, Li Y, Yan L, Lai X, Yang Q Front Public Health. 2024; 12:1420933.

PMID: 39440184 PMC: 11493668. DOI: 10.3389/fpubh.2024.1420933.


Liquid biopsy for early detection of lung cancer.

Bibikova M, Fan J Chin Med J Pulm Crit Care Med. 2024; 1(4):200-206.

PMID: 39171286 PMC: 11332910. DOI: 10.1016/j.pccm.2023.08.005.


Data mining-based identification of epigenetic signatures with discrimination potential of lung adenocarcinoma and squamous cell carcinoma.

Pang W, Ye M, Chen J, Zhang L, Wang Z Mol Biol Rep. 2024; 51(1):255.

PMID: 38302782 DOI: 10.1007/s11033-024-09216-y.


References
1.
Xinarianos G, McRonald F, Risk J, Bowers N, Nikolaidis G, Field J . Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer. Hum Mol Genet. 2006; 15(13):2038-44. DOI: 10.1093/hmg/ddl128. View

2.
Baryshnikova E, Destro A, Infante M, Cavuto S, Cariboni U, Alloisio M . Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin Cancer Res. 2008; 14(6):1913-9. DOI: 10.1158/1078-0432.CCR-07-1741. View

3.
Virmani A, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D . Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst. 2000; 92(16):1303-7. DOI: 10.1093/jnci/92.16.1303. View

4.
Shivapurkar N, Stastny V, Suzuki M, Wistuba I, Li L, Zheng Y . Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett. 2006; 247(1):56-71. PMC: 3379713. DOI: 10.1016/j.canlet.2006.03.020. View

5.
Zochbauer-Muller S, Lam S, Toyooka S, Virmani A, Toyooka K, Seidl S . Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer. 2003; 107(4):612-6. DOI: 10.1002/ijc.11458. View